Department of Medicine, McGill University, Montreal, QC, Canada.
Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Crit Care Med. 2021 Sep 1;49(9):1558-1566. doi: 10.1097/CCM.0000000000005026.
Severe acute respiratory syndrome-related coronavirus-2 binds and inhibits angiotensin-converting enzyme-2. The frequency of acute cardiac injury in patients with coronavirus disease 2019 is unknown. The objective was to compare the rates of cardiac injury by angiotensin-converting enzyme-2-binding viruses from viruses that do not bind to angiotensin-converting enzyme-2.
We performed a systematic review of coronavirus disease 2019 literature on PubMed and EMBASE.
We included studies with ten or more hospitalized adults with confirmed coronavirus disease 2019 or other viral pathogens that described the occurrence of acute cardiac injury. This was defined by the original publication authors or by: 1) myocardial ischemia, 2) new cardiac arrhythmia on echocardiogram, or 3) new or worsening heart failure on echocardiogram.
We compared the rates of cardiac injury among patients with respiratory infections with viruses that down-regulate angiotensin-converting enzyme-2, including H1N1, H5N1, H7N9, and severe acute respiratory syndrome-related coronavirus-1, to those with respiratory infections from other influenza viruses that do not bind angiotensin-converting enzyme-2, including Influenza H3N2 and influenza B.
Of 57 studies including 34,072 patients, acute cardiac injury occurred in 50% (95% CI, 44-57%) of critically ill patients with coronavirus disease 2019. The overall risk of acute cardiac injury was 21% (95% CI, 18-26%) among hospitalized patients with coronavirus disease 2019. In comparison, 37% (95% CI, 26-49%) of critically ill patients with other respiratory viruses that bind angiotensin-converting enzyme-2 (p = 0.061) and 12% (95% CI, 7-22%) of critically ill patients with other respiratory viruses that do not bind angiotensin-converting enzyme-2 (p < 0.001) experienced a cardiac injury.
Acute cardiac injury may be associated with whether the virus binds angiotensin-converting enzyme-2. Acute cardiac injury occurs in half of critically ill coronavirus disease 2019 patients, but only 12% of patients infected by viruses that do not bind to angiotensin-converting enzyme-2.
严重急性呼吸综合征相关冠状病毒-2 结合并抑制血管紧张素转换酶-2。目前尚不清楚 2019 年冠状病毒病患者急性心脏损伤的发生率。本研究旨在比较与不结合血管紧张素转换酶-2 的病毒相比,结合血管紧张素转换酶-2 的病毒引起的心脏损伤发生率。
我们在 PubMed 和 EMBASE 上对 2019 年冠状病毒病文献进行了系统评价。
我们纳入了十例或十例以上住院成人确诊 2019 年冠状病毒病或其他病毒病原体的研究,这些研究描述了急性心脏损伤的发生。这由原始出版物作者或以下标准定义:1)心肌缺血,2)超声心动图上出现新的心律失常,或 3)超声心动图上出现新的或恶化的心衰。
我们比较了与下调血管紧张素转换酶-2 的病毒(包括 H1N1、H5N1、H7N9 和严重急性呼吸综合征相关的冠状病毒-1)引起的呼吸道感染患者与不结合血管紧张素转换酶-2 的其他流感病毒(包括 H3N2 和流感 B)引起的呼吸道感染患者的心脏损伤发生率。
在纳入的 57 项研究中,共纳入了 34072 例患者,其中 50%(95%CI,44-57%)的 2019 年冠状病毒病危重症患者发生急性心脏损伤。2019 年住院的冠状病毒病患者总体急性心脏损伤风险为 21%(95%CI,18-26%)。相比之下,其他呼吸道结合血管紧张素转换酶-2 的病毒危重症患者中有 37%(95%CI,26-49%)(p=0.061),其他呼吸道不结合血管紧张素转换酶-2 的病毒危重症患者中有 12%(95%CI,7-22%)(p<0.001)发生心脏损伤。
急性心脏损伤可能与病毒是否结合血管紧张素转换酶-2有关。急性心脏损伤发生在一半的 2019 年冠状病毒病危重症患者中,但只有 12%的患者感染了不结合血管紧张素转换酶-2 的病毒。